General Information of the Compound
| Compound ID |
CP0526603
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S,5S,8R,12R)-5,8-dibenzyl-2-(1H-indol-3-ylmethyl)-12-piperidin-1-yl-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C38H44N6O4
|
||||||||||||||||||
| Molecular Weight |
648.808
|
||||||||||||||||||
| Canonical SMILES |
O=C1C[C@@H](N2CCCCC2)C(=O)NC[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)N1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H44N6O4/c45-35-23-34(44-18-10-3-11-19-44)38(48)40-25-29(20-26-12-4-1-5-13-26)41-36(46)32(21-27-14-6-2-7-15-27)43-37(47)33(42-35)22-28-24-39-31-17-9-8-16-30(28)31/h1-2,4-9,12-17,24,29,32-34,39H,3,10-11,18-23,25H2,(H,40,48)(H,41,46)(H,42,45)(H,43,47)/t29-,32+,33+,34-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ASEHDKSOPQBKAO-ODRDEDCPSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound